Companies / Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc.
Nasdaq: ODTXCIK 1882782BOSTON, MA
Ownership
48.1M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 0.63% | 301,842 |
| 10%+ / strategic | 7.68% | 3,690,146 |
| Institutions | 0.50% | 240,679 |
| Public float | 91.19% | 43,825,860 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 6
View all →| Insider | % of shares | Shares |
|---|---|---|
Tpg Gp a, LLC10% owner | 7.68% | 3,690,146 |
Leiden Jeffrey MDirector | 0.63% | 301,842 |
Coulter James G10% owner | — | — |
Smith Ian FDirector | — | — |
Walbert Timothy PDirector | — | — |
Winkelried Jon10% owner | — | — |
Institutional holders 1
View all →| Holder | Value | % of shares |
|---|---|---|
| $4.50M | 0.50% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | New | Common Stock | $4.50M | +241K | 240,679 0.50% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ODTX | Common Stock | 67613T104 |